We are excited to announce the publication of a new paper titled "Wellness in the Modulator Era: An Observational Study of the Impact of CFTR Modulator Therapy on the Well-being of People with Cystic Fibrosis" in the Journal of Cystic Fibrosis. This work includes contributions from our very own Aricca Van Citters and Joel King. This study explores the impact of CFTR modulator therapies on the health-related quality of life (HRQoL) and well-being of people with cystic fibrosis (PwCF). Through a cross-sectional observational approach, the...

read more